Company intelligence / Profile preview

Ovesco Endoscopy

Tübingen, Baden-Württemberg, Germanyovesco.com ↗

Ownership: Private
Employees: ~57
Development stage: Commercial

Overview

Ovesco’s products are widely used in clinical practice globally. The OTSC® system has been validated by over 600 studies including five randomized controlled trials for the treatment of GI hemorrhage and wall closure. The FTRD® enables minimally invasive full-thickness resections. HemoPill® provides rapid diagnosis of acute GI bleeding[2]. Products are CE-marked and commercially available.

Therapeutic areas: GastroenterologyOncology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Supports DEGEA as main sponsorGold Sponsor to Endoscopy Campusongoing collaborations with leading clinicians/scientists in endoscopy field

Beyond the preview

Go deeper on Ovesco Endoscopy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovesco Endoscopy.

Explore the full profile